Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.

Also called NCT02325830

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 163 participants (enrolled count) (from the registry)
Sponsor
Cardiac Dimensions Pty Ltd (from the registry)
Registry
  • NCT NCT02325830
Other papers using this trial's data
  • The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation JACC. Heart failure, 2019-11 DOI, PubMed 31521683

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Australia, Czechia, France, Germany, Netherlands, New Zealand, Poland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02325830. Randomized; double masking; primary purpose treatment. Start 2015-08-22 (actual); primary completion 2018-07-01 (actual). Results posted on 2024-08-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
Acronym
REDUCE FMR
Condition
Mitral Valve Insufficiency
Condition
Heart Failure
Intervention (Device)
Carillon Mitral Contour System
Lead sponsor
Cardiac Dimensions Pty Ltd (class: industry)
Collaborator
Menzies Institute for Medical Research (class: other)

Record details

Record id
cardio:ct-nct02325830
Content hash
0b6962ea1789558a601eb38edf7ff5877b199825eef8ad68ff6db098691a684e